Key result
HRV emerges as a dynamic, context-dependent biomarker for complementary cardiovascular risk assessment.
Why the study?
Reduced HRV is associated with adverse cardiovascular outcomes but its clinical use is limited by interpretive complexity and sensitivity to multiple factors.
When appropriately contextualized, HRV may serve as a complementary tool for cardiovascular risk assessment and provide insight into residual risk not fully captured by conventional clinical models.
HRV may complement risk assessment when contextualized; leaves open standardized clinical adoption pending prospective validation.
Heart rate variability (HRV) is a non-invasive marker of autonomic cardiovascular regulation that reflects beat-to-beat fluctuations in cardiac cycle length. Reduced HRV has been associated with adverse cardiovascular outcomes across multiple disease states, yet its clinical use remains limited by substantial interpretive complexity. Unlike static biomarkers, HRV is highly sensitive to measurement modality, recording duration, circadian timing, behavioral factors, environmental exposures, medications, and comorbidities. Therefore, isolated HRV values cannot be interpreted as direct indicators of autonomic health without careful consideration of context. This review summarizes the physiological basis of HRV, key time-domain, frequency-domain, and nonlinear/complexity metrics, and major acquisition methods, including 24 h electrocardiography (ECG), short-term ECG, chest strap monitors, and wrist-worn devices. It also examines how sleep, physical activity, diet, psychological stress, substance use, age and sex, medications, and cardiovascular or metabolic diseases influence HRV interpretation. We propose a context-aware framework for interpreting HRV as a dynamic physiological signal rather than a standalone diagnostic marker. When appropriately contextualized, HRV may serve as a complementary tool for cardiovascular risk assessment and provide insight into residual risk not fully captured by conventional clinical models.
No takes yet. Share an insight, caveat, or question.
Ghazzal et al. (2026) conducted a review in Cardiovascular risk and autonomic regulation. Heart rate variability (HRV) assessment was evaluated. Heart rate variability is a dynamic, context-dependent biomarker that may serve as a complementary tool for cardiovascular risk assessment when appropriately contextualized.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: